This D.C. biotech is raising millions to catch heart attacks before they strike — with a simple blood test

Favicon The Washington Business Journal

True Bearing Diagnostics Inc. is working to commercialize an early-detection test for coronary artery disease, a possible game-changer for the health care industry, which currently relies on the more invasive and expensive cardiac catheterization or nuclear imaging after patients exhibit symptoms.

Read the full article here: The Washington Business Journal


The post: «This D.C. biotech is raising millions to catch heart attacks before they strike — with a simple blood test» has been published on the website The Washington Business Journal where, everyday, you can find the latest news about Washington's area.



Get more articles about this topic

Leave a comment